findmyKOL

Cory Dunnick, MD

Enriched profile

Professor of Dermatology · University of Colorado Anschutz Medical Campus

ORCIDNPI
Region🇺🇸 Aurora, CO · West · United StatesSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceverified 2026Payments2023–2025NIH funding2019–2021

Cory Dunnick is Professor of Dermatology at University of Colorado Anschutz Medical Campus. OpenAlex indexes 164 publications with 5,111 citations (h-index 32); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Cory A. Dunnick, MD, is Professor of Dermatology at University of Colorado Anschutz Medical Campus, Department of Dermatology. The public record shows 164 publications with 5,111 citations (h-index 32), centered on Dermatology. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 19 companies, 1 NIH-funded awards (2019–2021).

  • Most recent indexed publication: 2025 · JMIR medical education
  • Top research focus: Dermatology
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 19 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Dermatitis, Contact2 trialsDermatitis, Allergic Contact1 trial

Research focus

OpenAlex concept fingerprint
Dermatology

Drugs & molecules

across trials, industry payments and publications
Litfulogeneric · RitlecitinibClinical trialsIndustry payments26PublicationsCibinqogeneric · AbrocitinibClinical trialsIndustry payments22PublicationsDupixentgeneric · DupilumabClinical trialsIndustry payments19Publications

Works with

trial sponsors and companies reporting payments
Pfizer Inc.Clinical trialsIndustry payments35LEO Pharma Inc.Clinical trialsIndustry payments14Abbvie Inc.Clinical trialsIndustry payments10

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
164publications

Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.

5,111citations

Total citations across indexed works.

32h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
19companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2019–2021

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

19 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    32.8%
    Corticosteroid21.2%
    Triamcinolone Acetonide100%
    Part D23 patients
    Other antifungals for topical use11.6%
    Ciclopirox100%
    Part D12 patients
  • Anti-infectives

    32.3%
    Azole Antifungal19.6%
    Ketoconazole100%
    Part D32 patients
    Lincosamide Antibacterial6.3%
    Clindamycin Phosphate100%
    Part D<11 patients
  • Sensory organs

    24.9%
    Corticosteroid24.9%
    Clobetasol Propionate66%Hydrocortisone34%
    Part D<11 patients
1 more therapeutic area behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

1 NIH research award on record, funded 20192021 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/cory-dunnick-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • Profiles.ucdenver.edu

    Faculty research profile listing 125 publications (1996-2026); topics include contact dermatitis, occupational dermatology, patch testing

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucdenver.edu

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    American Board of Dermatology

    2030
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →contactderm.org
  • Residency

    Dermatology, Vanderbilt University Medical Center

    2000
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →contactderm.org
  • MD

    University of North Carolina at Chapel Hill School of Medicine

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →contactderm.org
  • BS

    University of North Carolina at Chapel Hill

    1992
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →som.cuanschutz.edu

Editorial & leadership roles

journal and society appointments
  • Director

    Dermatitis and Contact Allergy Clinic, University of Colorado

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu
  • Director

    Clinical Trials Center, Department of Dermatology, University of Colorado

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu

Awards & honors

honors on the public record
5 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Dermatologist

    Colorado Skin Surgery & Dermatology (private practice), 2022 - present

    2022
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →contactderm.org
  • Staff Physician

    Dermatology Service, Rocky Mountain Regional Veterans Affairs Medical Center, 2012 - present

    2012
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →contactderm.org
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →som.cuanschutz.edu

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.